Primary Site >> Stomach Cancer
Gene >> KLRK1
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. PMID: 16630603 |
Ref: Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer. PMID: 17255258 |
Ref: [Mechanistic study of nimesulide on enhancing gammadeltaT cell-mediated killing of gastric cancer cells]. PMID: 20230693 |
Ref: Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer. PMID: 21215924 Ref: Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy. PMID: 21314289 |
Ref: Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer. PMID: 21626292 Ref: Decreased number and reduced NKG2D expression of Vdelta1 gammadelta T cells are involved in the impaired function of Vdelta1 gammadelta T cells in the tissue of gastric cancer. PMID: 22252158 Ref: Interleukin-1beta enhances the production of soluble MICA in human hepatocellular carcinoma. PMID: 22302133 Ref: Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity. PMID: 22415659 |
Ref: Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. PMID: 24138752 Ref: Effect of vasoactive intestinal peptide (VIP) on NKG2D signal pathway and its contribution to immune escape of MKN45 cells. PMID: 24228003 |
Ref: Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer. PMID: 24615495 |
Ref: Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cells. PMID: 26543378 Ref: MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells. PMID: 26693072 |
Ref: Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer. PMID: 26607264 Ref: Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients. PMID: 26708143 Ref: Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility. PMID: 27002316 Ref: Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer. PMID: 27409423 |
Ref: Human fused NKG2D-IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells. PMID: 26364916 Ref: DKK3 attenuates the cytotoxic effect of natural killer cells on CD133(+) gastric cancer cells. PMID: 28218426 Ref: Prognostic significance and functional implication of immune activating receptor NKG2D in gastric cancer. PMID: 28433635 |
Ref: Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy. PMID: 29391893 Ref: Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment. PMID: 30132099 Ref: Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer. PMID: 30255106 |